TY  - RPRT
TI  - Correlation analysis of target selectivity and side effects of FDA-approved kinase inhibitors
AU  - Bayazeid, O.
AU  - Rahman, T.
PY  - 2021
DO  - 10.1101/2021.03.18.435943
UR  - https://www.biorxiv.org/content/10.1101/2021.03.18.435943v1
ID  - 10.1101/2021.03.18.435943
ER  -